Amgen, Inc. (AMGN)
403.04
-4.23
(-1.04%)
USD |
NASDAQ |
Oct 02, 16:00
403.83
+0.79
(+0.20%)
After-Hours: 20:00
Amgen Market Cap : 217.88B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 217.88B |
| October 01, 2026 | 220.17B |
| September 30, 2026 | 227.87B |
| September 29, 2026 | 229.02B |
| September 28, 2026 | 226.04B |
| September 25, 2026 | 224.14B |
| September 24, 2026 | 219.51B |
| September 23, 2026 | 219.53B |
| September 22, 2026 | 221.78B |
| September 21, 2026 | 212.54B |
| September 18, 2026 | 208.48B |
| September 17, 2026 | 205.31B |
| September 16, 2026 | 203.45B |
| September 15, 2026 | 203.08B |
| September 14, 2026 | 206.24B |
| September 11, 2026 | 204.00B |
| September 10, 2026 | 206.76B |
| September 09, 2026 | 211.52B |
| September 08, 2026 | 212.55B |
| September 04, 2026 | 236.37B |
| September 03, 2026 | 240.09B |
| September 02, 2026 | 239.40B |
| September 01, 2026 | 236.85B |
| August 31, 2026 | 232.39B |
| August 28, 2026 | 233.77B |
| Date | Value |
|---|---|
| August 27, 2026 | 236.24B |
| August 26, 2026 | 238.05B |
| August 25, 2026 | 239.07B |
| August 24, 2026 | 239.94B |
| August 21, 2026 | 237.50B |
| August 20, 2026 | 234.47B |
| August 19, 2026 | 239.14B |
| August 18, 2026 | 229.91B |
| August 17, 2026 | 226.72B |
| August 14, 2026 | 224.46B |
| August 13, 2026 | 225.88B |
| August 12, 2026 | 224.99B |
| August 11, 2026 | 223.97B |
| August 10, 2026 | 225.54B |
| August 07, 2026 | 222.16B |
| August 06, 2026 | 218.86B |
| August 05, 2026 | 220.47B |
| August 04, 2026 | 210.84B |
| August 03, 2026 | 204.82B |
| July 31, 2026 | 208.22B |
| July 30, 2026 | 209.56B |
| July 29, 2026 | 209.56B |
| July 28, 2026 | 212.51B |
| July 27, 2026 | 203.41B |
| July 24, 2026 | 203.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 179.62B |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
| AbbVie, Inc. | 464.42B |
| Biogen, Inc. | 32.48B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
Market Cap Related Metrics
| PE Ratio | 25.04 |
| PS Ratio | 5.731 |
| PEG Ratio | 0.7897 |
| Price to Book Value | 18.64 |
| Price to Free Cash Flow | 21.52 |
| Price | 403.04 |
| Earnings Yield | 3.99% |
| PEGY Ratio | 0.7327 |
| Operating PE Ratio | 17.21 |
| Normalized PE Ratio | 22.85 |